What You Should Know:
– Premier, Inc., a healthcare improvement company, has announced a definitive agreement to be acquired by an affiliate of Patient Square Capital.
– Under the terms of the agreement, Premier stockholders will receive $28.25 in cash per share valued at $2.6B, which represents a 23.8% premium to the company’s 60-day volume-weighted average price as of September 5, 2025. The transaction has been unanimously approved by Premier’s Board of Directors.
Premier, Inc. Goes Private
According to Richard Statuto, Premier’s Board Chair, the decision came after careful consideration of various strategic alternatives. He stated that the transaction is in the best interests of the company and its stockholders, providing “immediate and certain value” while also giving Premier access to additional capital to accelerate support and services for its members.
The acquisition is expected to close by the first quarter of calendar year 2026, subject to approval by Premier stockholders and regulatory approvals. Upon completion, Premier will become a private company, and its common stock will no longer be traded on any public exchange. In connection with the transaction, Premier will suspend the declaration and distribution of common stock dividends in future quarters.
“We have long admired Premier as an innovator of essential services and products to its members, which are leading institutions and providers in the U.S. health care system. Our team sees tremendous opportunity for Premier to continue growing its differentiated portfolio in supply chain services, data and technology offerings, and consulting solutions that deliver value to patients, and we look forward to working closely with the team as a private company,” said Patient Square Founding Partner Neel Varshney, M.D.
